HU9800369D0 - Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production - Google Patents

Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production

Info

Publication number
HU9800369D0
HU9800369D0 HU9800369A HUP9800369A HU9800369D0 HU 9800369 D0 HU9800369 D0 HU 9800369D0 HU 9800369 A HU9800369 A HU 9800369A HU P9800369 A HUP9800369 A HU P9800369A HU 9800369 D0 HU9800369 D0 HU 9800369D0
Authority
HU
Hungary
Prior art keywords
pellet
potassium
chloride
production
pharmaceutical composition
Prior art date
Application number
HU9800369A
Other languages
Hungarian (hu)
Inventor
Tibor Nagy
Karoly Pataki
Gabor Guenther
Pal Fekete
Gabor Farago
Blanka Lady
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU9800369A priority Critical patent/HU221435B/en
Publication of HU9800369D0 publication Critical patent/HU9800369D0/en
Priority to AU25404/99A priority patent/AU2540499A/en
Priority to PL343268A priority patent/PL193028B1/en
Priority to SK1188-2000A priority patent/SK287281B6/en
Priority to CZ20002858A priority patent/CZ299182B6/en
Priority to PCT/HU1999/000013 priority patent/WO1999042087A2/en
Publication of HUP9800369A1 publication Critical patent/HUP9800369A1/en
Publication of HU221435B publication Critical patent/HU221435B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
HU9800369A 1998-02-20 1998-02-20 Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production HU221435B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU9800369A HU221435B (en) 1998-02-20 1998-02-20 Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
AU25404/99A AU2540499A (en) 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
PL343268A PL193028B1 (en) 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
SK1188-2000A SK287281B6 (en) 1998-02-20 1999-02-19 Controlled release multi-dosage pharmaceutical composition in solid peroral form and method for the preparation thereof
CZ20002858A CZ299182B6 (en) 1998-02-20 1999-02-19 Multiple dosage controlled release pharmaceutical composition in peroral solid form, preferably in tablet or hard gelatin pellet form containing potassium chloride
PCT/HU1999/000013 WO1999042087A2 (en) 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9800369A HU221435B (en) 1998-02-20 1998-02-20 Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production

Publications (3)

Publication Number Publication Date
HU9800369D0 true HU9800369D0 (en) 1998-04-28
HUP9800369A1 HUP9800369A1 (en) 2000-08-28
HU221435B HU221435B (en) 2002-10-28

Family

ID=89996172

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800369A HU221435B (en) 1998-02-20 1998-02-20 Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production

Country Status (6)

Country Link
AU (1) AU2540499A (en)
CZ (1) CZ299182B6 (en)
HU (1) HU221435B (en)
PL (1) PL193028B1 (en)
SK (1) SK287281B6 (en)
WO (1) WO1999042087A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928312A1 (en) * 1999-06-16 2000-12-21 Schering Ag Drug preparation with delayed drug delivery
DE10347242A1 (en) * 2003-10-10 2005-05-04 Wella Ag Dye-containing pellets for dyeing keratin fibers
EP2023903B1 (en) * 2006-05-19 2014-04-23 EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság Process for the preparation and surface coating of pellets
DE102008063800A1 (en) 2008-12-19 2010-06-24 Henkel Ag & Co. Kgaa Coated colorants
CN102961363B (en) * 2012-12-14 2014-09-17 河南中帅医药科技股份有限公司 Potassium chloride slow release capsule
EP3213747B1 (en) 2016-03-04 2019-02-13 Laboratorio Reig Jofre S.A. Tablets with a high-content of active ingredients useful for treating hair loss or stimulating its growth
EP4308286A1 (en) 2021-03-16 2024-01-24 Symrise AG Active substance capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052075A1 (en) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Sustained release pharmaceutical granule
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
CH658188A5 (en) * 1984-03-23 1986-10-31 Ciba Geigy Ag STORAGE STABLE QUICK DISASSEMBLING PHARMACEUTICAL PRESSELS.
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form

Also Published As

Publication number Publication date
SK287281B6 (en) 2010-05-07
SK11882000A3 (en) 2001-01-18
AU2540499A (en) 1999-09-06
CZ299182B6 (en) 2008-05-14
WO1999042087A3 (en) 1999-11-25
PL343268A1 (en) 2001-08-13
PL193028B1 (en) 2007-01-31
WO1999042087A2 (en) 1999-08-26
HU221435B (en) 2002-10-28
HUP9800369A1 (en) 2000-08-28
CZ20002858A3 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
HUP0102084A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103224A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9801688A3 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
HUP9700344A3 (en) Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP9902850A3 (en) Quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
MXPA00012199A (en) Modified gellan gum composition process for preparation of same and use thereof.
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9800781A3 (en) Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP0102622A2 (en) Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them
HUP0001522A3 (en) Benzoimidazole derivatives, process for producing them and pharmaceutical compositions containing them
HUT75516A (en) Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria, pharmaceutical compositions containing them and process for their production
HUP0104985A3 (en) Pharmaceutical levothyroxine compositions and process for their preparation
HUT67142A (en) Spirostanil glycosidal cristalline monohydrate, pharmaceutical compositions containing the same and process for their production
HUP0103533A3 (en) Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HU9800369D0 (en) Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
HUP0001827A3 (en) Colchicine derivatives, process for producing them, pharmaceutical compositions containing them, and use thereof for producing pharmaceutical compositions
HUP9701921A3 (en) Heterocyclic amino-methyl compounds, process for producing them, and pharmaceutical compositions containing them
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
HUP9702227A3 (en) New benzopirane compounds, process for producing them and pharmaceutical composition containing them
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation
HUP0002491A3 (en) Polymer composition, process for producing thereof and its use

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYRT., HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU